Experience with Balloon Dilatation in Crohn's and Non-Crohn's Benign Small-Bowel Strictures: Is There a Difference?


Journal

Gastroenterology research and practice
ISSN: 1687-6121
Titre abrégé: Gastroenterol Res Pract
Pays: Egypt
ID NLM: 101475557

Informations de publication

Date de publication:
2019
Historique:
received: 26 12 2018
revised: 06 03 2019
accepted: 21 03 2019
entrez: 15 6 2019
pubmed: 15 6 2019
medline: 15 6 2019
Statut: epublish

Résumé

Endoscopic balloon dilation (EBD) has been effective for small-bowel strictures in patients with Crohn's disease (CD). However, its efficacy and indication for small-bowel strictures in non-CD patients have not been established. This study evaluated the clinical efficacy and safety of EBD for small-bowel strictures in non-CD patients compared with CD patients. Ninety-eight consecutive patients (mean age, 53 years; average observation period, 45 months) with small-bowel strictures diagnosed by double-balloon endoscopy were retrospectively evaluated at Hiroshima University Hospital from August 2003 to April 2017. The average number of procedures, short-term and long-term EBD success rates, and safety profiles between the non-CD and CD groups were examined. Surgery was selected as the initial treatment in 44 cases (45%) (non-CD group, 27 (61%); CD group, 17 (39%)) as EBD is not indicated. Fourteen non-CD patients had strictures due to malignant tumors, while 13 patients had benign strictures. Twenty-three patients (non-CD, 12; CD, 11) underwent EBD. Forty-three EBD procedures were performed for 17 stricture sites (average: 2.5 procedures/site) in non-CD patients and 41 EBD procedures for 18 stricture sites (average: 2.3 procedures/site) in CD patients. The short-term success rate was 100% (23/23), whereas the long-term success rate was 92% (11/12) in non-CD patients and 82% (9/11) in CD patients. No significant differences in the surgery-free rate occurred between both groups. Furthermore, one adverse event, bleeding after EBD, was encountered in the non-CD group (8%, 1/12). EBD for small-bowel strictures demonstrated good clinical outcomes in non-CD patients.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Endoscopic balloon dilation (EBD) has been effective for small-bowel strictures in patients with Crohn's disease (CD). However, its efficacy and indication for small-bowel strictures in non-CD patients have not been established. This study evaluated the clinical efficacy and safety of EBD for small-bowel strictures in non-CD patients compared with CD patients.
METHODS METHODS
Ninety-eight consecutive patients (mean age, 53 years; average observation period, 45 months) with small-bowel strictures diagnosed by double-balloon endoscopy were retrospectively evaluated at Hiroshima University Hospital from August 2003 to April 2017. The average number of procedures, short-term and long-term EBD success rates, and safety profiles between the non-CD and CD groups were examined.
RESULTS RESULTS
Surgery was selected as the initial treatment in 44 cases (45%) (non-CD group, 27 (61%); CD group, 17 (39%)) as EBD is not indicated. Fourteen non-CD patients had strictures due to malignant tumors, while 13 patients had benign strictures. Twenty-three patients (non-CD, 12; CD, 11) underwent EBD. Forty-three EBD procedures were performed for 17 stricture sites (average: 2.5 procedures/site) in non-CD patients and 41 EBD procedures for 18 stricture sites (average: 2.3 procedures/site) in CD patients. The short-term success rate was 100% (23/23), whereas the long-term success rate was 92% (11/12) in non-CD patients and 82% (9/11) in CD patients. No significant differences in the surgery-free rate occurred between both groups. Furthermore, one adverse event, bleeding after EBD, was encountered in the non-CD group (8%, 1/12).
CONCLUSION CONCLUSIONS
EBD for small-bowel strictures demonstrated good clinical outcomes in non-CD patients.

Identifiants

pubmed: 31198420
doi: 10.1155/2019/1262595
pmc: PMC6526561
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1262595

Références

Gastrointest Endosc. 2001 Feb;53(2):216-20
pubmed: 11174299
J Clin Oncol. 2001 Sep 15;19(18):3874-83
pubmed: 11559725
Cancer. 2003 May 15;97(10):2462-73
pubmed: 12733145
J Clin Oncol. 2003 Jul 15;21(14):2740-6
pubmed: 12860953
J Clin Pathol. 2004 Nov;57(11):1145-50
pubmed: 15509673
Clin Gastroenterol Hepatol. 2004 Nov;2(11):1010-6
pubmed: 15551254
Gut. 2006 Sep;55(9):1372
pubmed: 16905713
Gastrointest Endosc. 2006 Nov;64(5):835-7
pubmed: 17055891
Gastrointest Endosc. 2006 Dec;64(6):1014-7
pubmed: 17140921
Dig Liver Dis. 2007 Jun;39(6):597-8
pubmed: 17420160
Inflammopharmacology. 2007 Apr;15(2):74-7
pubmed: 17450446
J Int Med Res. 2007 May-Jun;35(3):406-15
pubmed: 17593870
Rinsho Ketsueki. 2007 Jun;48(6):510-3
pubmed: 17633101
Gastrointest Endosc. 2007 Sep;66(3 Suppl):S108-12
pubmed: 17709019
Br J Haematol. 2008 Mar;140(6):712-4
pubmed: 18218049
Am J Gastroenterol. 2008 Oct;103(10):2656-7
pubmed: 18855864
Histopathology. 2008 Oct;53(4):432-40
pubmed: 18983608
Gastrointest Endosc. 2009 Jan;69(1):84-93
pubmed: 19111689
J Gastroenterol. 2009;44 Suppl 19:57-63
pubmed: 19148795
Gastrointest Endosc. 2009 Nov;70(5):1030-6
pubmed: 19640518
Saudi J Gastroenterol. 2007 Jul-Sep;13(3):133-5
pubmed: 19858630
Am J Gastroenterol. 2010 Feb;105(2):289-97
pubmed: 19861953
Gastrointest Endosc. 2010 Feb;71(2):422-5
pubmed: 19896664
Dig Endosc. 2010 Jul;22(3):200-4
pubmed: 20642609
Case Rep Gastroenterol. 2010 Sep 11;4(3):323-329
pubmed: 21060694
Gastrointest Endosc. 2011 Sep;74(3):563-70
pubmed: 21620401
Gastrointest Endosc. 2011 Nov;74(5):1157-61
pubmed: 21924719
Hepatogastroenterology. 2012 Jun;59(116):955-9
pubmed: 22580642
Hepatogastroenterology. 2012 Jun;59(116):1081-6
pubmed: 22580659
Dig Endosc. 2012 Jul;24(4):209-19
pubmed: 22725104
Ann Oncol. 2013 Sep;24(9):2439-43
pubmed: 23704194
Dig Endosc. 2014 Jul;26(4):545-51
pubmed: 24528293
Ann Gastroenterol. 2013;26(2):141-145
pubmed: 24714760
Therap Adv Gastroenterol. 2014 May;7(3):108-14
pubmed: 24790641
Inflamm Bowel Dis. 2016 Feb;22(2):380-6
pubmed: 26535767
Dig Liver Dis. 2016 Apr;48(4):446-8
pubmed: 26725164
Intest Res. 2016 Jan;14(1):89-95
pubmed: 26884740
J Assoc Physicians India. 2016 Feb;64(2):38-47
pubmed: 27730779
World J Gastroenterol. 2016 Oct 28;22(40):9022-9027
pubmed: 27833393
World J Gastroenterol. 2017 Dec 7;23(45):8073-8081
pubmed: 29259383
Med Clin North Am. 1988 Sep;72(5):1091-115
pubmed: 3045452
J Clin Pathol. 1988 May;41(5):516-26
pubmed: 3384981
J Surg Oncol. 1997 Mar;64(3):237-41
pubmed: 9121156
Endoscopy. 1998 Mar;30(3):S44
pubmed: 9615897
J Intern Med. 1998 Jul;244(1):71-8
pubmed: 9698027

Auteurs

Akiyoshi Tsuboi (A)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.

Shiro Oka (S)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.

Shinji Tanaka (S)

Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.

Sumio Iio (S)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.

Ichiro Otani (I)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.

Sayoko Kunihara (S)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.

Ryohei Hayashi (R)

Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.

Kazuaki Chayama (K)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.

Classifications MeSH